Why Join?

Clinical studies are the backbone of drug development.

Have you ever thought closely about the contents of your medicine cabinet? The medicines inside may have different purposes, but they have one big thing in common: before reaching you, they underwent years of scientific studies to ensure they were safe for you to take. These research studies are called clinical studies. 

Clinical studies provide critical information about an investigational drug’s safety and effectiveness and generate in-depth data that can even lead to the creation of other innovative treatments. Every potential drug undergoes multiple phases of research, each with a different goal.

Ultimately, clinical studies make a difference not just for today’s patients, but also potentially to those who’ll be diagnosed tomorrow, next month, or even a decade from now.

The whole experience has been a joy and the personnel are all so professional.

Patient from our South London Clinic

The staff were all friendly and showed great professionalism.  10 out of 10 for each of them.

Patient from our Lakeside Clinic

Phases of clinical studies

Clinical studies are usually conducted in three phases (I,II and III). Only a small number of volunteers, usually so called 'healthy volunteers’, participate in phase I trials, while the later phases involve a larger number of patient volunteers. 

At MeDiNova, we focus on what’s known as “late phase” clinical studies. These studies look into the effects the treatments being researched have on the conditions they were designed to treat and all will have undergone some earlier phase testing.

Download our Brochure

Regulations

Clinical studies have a regulatory and ethical framework to protect participants. Everyone conducting a clinical study has strict regulatory and ethical duties. To ensure these duties are followed and that participants are treated well, a team of people, who are independent from the research conduct, is asked to review and maintain oversight over each clinical study.

A clinical study can only be offered to our study patients once it has been approved in the UK by the MHRA (Medicines and Healthcare Products Regulatory Agency), as well as an independent ethics committee who look to ensure that the rights and wellbeing of all study patients are not being compromised. 

Many studies, particularly phase III studies are conducted worldwide with a large number of patients participating in them. They will have to be approved by the regulatory agencies in their countries (e.g the FDA in the United States) and the results collected from all study participants globally are monitored closely during the study process.

All our clinical studies are fully approved by both national and local ethics committees. As well as being rigorously monitored by both internal and external audits along with regulatory inspections throughout.

  • How does a Clinical trial work?
  • Who can participate in a clinical trial?
  • What are the possible benefits of taking part?
  • How do I find out about current studies?

The majority of clinical study participants would do it again. 

An estimated 2.3 million people participated in clinical studies in 2015. During that same year, a survey by the Centre for Information and Study on Clinical Research Participation (CISCRP) found that 98% of clinical study participants would consider enrolling in another clinical study. Additionally, 92% of respondents thought their clinical study experience met or exceeded their expectations.